SG Americas Securities’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-90,000
Closed -$14K 3824
2021
Q2
$14K Buy
+90,000
New +$2.73M ﹤0.01% 2790
2019
Q2
Sell
-18,400
Closed -$4K 3087
2019
Q1
$4K Sell
18,400
-173,100
-90% -$4.13M ﹤0.01% 3320
2018
Q4
$10K Buy
191,500
+91,500
+92% +$2.18M ﹤0.01% 2941
2018
Q3
$218K Buy
100,000
+56,200
+128% +$1.29M ﹤0.01% 2518
2018
Q2
$11K Sell
43,800
-1,411,200
-97% -$29.2M ﹤0.01% 3261
2018
Q1
$35K Buy
+1,455,000
New +$27.1M ﹤0.01% 3121

Other funds holding BHC

SG Americas Securities's BHC Position: Q1 2026 in Review

SG Americas Securities increased its Bausch Health (BHC) stake by 3.3% in Q1 2026, buying an estimated $2.85K and bringing the position to 14,810 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #2972.

SG Americas Securities first reported a position in BHC in Q2 2013 and has held it in 39 quarters since. The position peaked at $41M in Q2 2025. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • SG Americas Securities held 14,810 shares of Bausch Health worth $80K as of Q1 2026.
  • SG Americas Securities bought 476 Bausch Health shares in Q1 2026, an estimated $2.85K.
  • Bausch Health made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2972 holding.
  • SG Americas Securities first reported a position in Bausch Health in Q2 2013 and has held it in 39 quarters since.
  • SG Americas Securities's Bausch Health position peaked at $41M in Q2 2025.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.